Overexpression of glutathione S-transferase π enhances the adduct formation of cisplatin with glutathione in human cancer cells

被引:164
作者
Goto, S
Iida, T
Cho, S
Oka, M
Kohno, S
Kondo, T [1 ]
机构
[1] Nagasaki Univ, Sch Med, Atom Bomb Dis Inst, Dept Biochem & Mol Biol Dis, Nagasaki 8528523, Japan
[2] Nagasaki Univ, Sch Med, Dept Med, Nagasaki 8528523, Japan
关键词
glutathione S-transferase pi; cisplatin; adduct;
D O I
10.1080/10715769900301121
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this paper, we provide direct evidence that glutathione S-transferase pi (GST pi) detoxifies cisplatin (CDDP). We used human colonic cancer HCT8 cells sensitive and resistant to CDDP, the level of cisplatin-glutathione adduct (DDP-GSH) being higher in the resistant cells. There was an overexpression of GST pi mRNA in these CDDP-resistant cells. Incubation of the cells with CDDP resulted in the formation of DDP-GSH dependent on the CDDP concentration and the incubation time. The formation of DDP-GSH was abolished when the cells were pre-treated with ethacrynic acid or ketoprofen, inhibitors of GST pi. Purified GST pi also catalyzed the formation of DDP-GSH in vitro, with an apparent K-m of 0.23 mM for CDDP and an apparent V-max of 4.9 nmol/min/mg protein. The increase in DDP-GSH produced by GST pi was linear with incubation time up to 3 h and optimal of pH 7.4. A GST ii transfectant cell line was constructed in HCT8 cells using a pcDNA3.1 (-)/Myc-His B with an expression vector containing cDNA for GST pi. Transfection of GST pi cDNA into HCT8 cells resulted in an increase in the expression of GST pi by 1.4-fold in parallel with an augmentation of the formation of DDP-GSH. These results suggest that GST pi Flays a role in the formation of DDP-GSH and the acquisition of resistance to CDDP in cancer cells.
引用
收藏
页码:549 / 558
页数:10
相关论文
共 31 条
[1]   IMAGING PLATE ILLUMINATES MANY FIELDS [J].
AMEMIYA, Y ;
MIYAHARA, J .
NATURE, 1988, 336 (6194) :89-90
[2]  
Ban N, 1996, CANCER RES, V56, P3577
[3]  
Beutler E, 1984, RED CELL METABOLISM, P77
[4]  
CHECTER RL, 1992, CANCER RES, V53, P4900
[5]  
CHU G, 1994, J BIOL CHEM, V269, P787
[6]  
DOROSHOW JH, 1995, CANCER RES, V55, P4073
[7]   HIGH-RESISTANCE TO CISPLATIN IN HUMAN OVARIAN-CANCER CELL-LINES IS ASSOCIATED WITH MARKED INCREASE OF GLUTATHIONE SYNTHESIS [J].
GODWIN, AK ;
MEISTER, A ;
ODWYER, PJ ;
HUANG, CS ;
HAMILTON, TC ;
ANDERSON, ME .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (07) :3070-3074
[8]  
GOTO S, 1995, CANCER RES, V55, P4297
[9]   PURIFICATION OF GLUTATHIONE S-TRANSFERASE FROM HUMAN-PLACENTA [J].
GUTHENBERG, C ;
AKERFELDT, K ;
MANNERVIK, B .
ACTA CHEMICA SCANDINAVICA SERIES B-ORGANIC CHEMISTRY AND BIOCHEMISTRY, 1979, 33 (08) :595-596
[10]   AUGMENTATION OF ADRIAMYCIN, MELPHALAN, AND CISPLATIN CYTO-TOXICITY IN DRUG-RESISTANT AND DRUG-SENSITIVE HUMAN OVARIAN-CARCINOMA CELL-LINES BY BUTHIONINE SULFOXIMINE MEDIATED GLUTATHIONE DEPLETION [J].
HAMILTON, TC ;
WINKER, MA ;
LOUIE, KG ;
BATIST, G ;
BEHRENS, BC ;
TSURUO, T ;
GROTZINGER, KR ;
MCKOY, WM ;
YOUNG, RC ;
OZOLS, RF .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (14) :2583-2586